| Not Yet Recruiting | FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Micros Ras-mutated Metastatic Colorectal Cancer, mCRC, MSS Metastatic Colorectal Cancer | Phase 2 | 2026-04-30 |
| Recruiting | A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep an Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic | Phase 1 / Phase 2 | 2021-10-27 |
| Active Not Recruiting | A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With Breast Cancer Metastatic | Phase 2 | 2020-06-10 |
| Terminated | A Window-of-opportunity Study of Pelareorep in Early Breast Cancer Breast Cancer | EARLY_Phase 1 | 2019-03-29 |
| Withdrawn | Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle Muscle-invasive Transitional Cell Carcinoma of the Bladder | Phase 1 | 2017-02-28 |
| Completed | Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma | Phase 1 | 2015-12-01 |
| Completed | Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Meta KRAS Mutant Metastatic Colorectal Cancer | Phase 1 | 2010-12-01 |
| Completed | Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Nec Carcinoma, Squamous Cell of the Head and Neck | Phase 3 | 2010-06-01 |
| Completed | A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2009-10-01 |
| Completed | A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma o Metastatic or Recurrent Squamous Cell Carcinoma of the Lung | Phase 2 | 2009-10-01 |
| Completed | Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma Metastatic Melanoma | Phase 2 | 2009-09-01 |
| Completed | Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With Carcinoma, Non-small Cell Lung | Phase 2 | 2009-03-01 |
| Completed | Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carci Carcinoma, Squamous Cell of the Head and Neck | Phase 2 | 2008-08-01 |
| Completed | Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lun Osteosarcoma, Ewing Sarcoma Family Tumors, Malignant Fibrous Histiocytoma | Phase 2 | 2007-06-01 |
| Completed | Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas Malignant Glioma | Phase 1 | 2006-07-01 |